Literature DB >> 25713841

GAVI exceeds US$7.5 billion fundraising target.

Ann Danaiya Usher.   

Abstract

Mesh：

Year:  2015        PMID： 25713841     DOI： 10.1016/s0140-6736(15)60185-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Pneumococcal conjugate vaccination schedules in infants-acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study.

Authors:  Grant A Mackenzie; Isaac Osei; Rasheed Salaudeen; Ousman Secka; Umberto D'Alessandro; Ed Clarke; Jonas Schmidt-Chanasit; Paul V Licciardi; Cattram Nguyen; Brian Greenwood; Kim Mulholland
Journal:  Trials       Date:  2022-01-15       Impact factor: 2.728

2.  A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial.

Authors:  Grant A Mackenzie; Isaac Osei; Rasheed Salaudeen; Ilias Hossain; Benjamin Young; Ousman Secka; Umberto D'Alessandro; Arto A Palmu; Jukka Jokinen; Jason Hinds; Stefan Flasche; Kim Mulholland; Cattram Nguyen; Brian Greenwood
Journal:  Trials       Date:  2022-01-24       Impact factor: 2.728
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.